基于金属有机框架的可变尺寸纳米颗粒用于瘤微环境响应药物输送
Yu Wang1, Nan Gao1, Xiaodan Li2
1Wuya College of Innovation, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang, 110016, China.
Drug delivery and translational research
|February 8, 2024
概括
研究人员使用金属有机框架 (MOFs) 开发了可变大小的纳米粒子,以增强瘤向. 这些可适应的纳米粒子通过响应瘤微环境 (TME) 来改善药物输送并降低毒性.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
背景情况:
- 单个尺寸的纳米粒子 (NP) 面临着由于血液循环和积累不良而导致瘤治疗的局限性.
- NP大小极大地影响清除,瘤透和全身毒性,需要新的方法.
研究的目的:
- 引入和审查基于金属有机框架 (MOFs) 的可变尺寸纳米粒子 (NP),以改善瘤治疗.
- 探索基于MOF的NP的优势和机制,这些NP在瘤微环境 (TME) 中适应其大小.
主要方法:
- 根据大小变化对MOFNP进行分类.
- 根据TME特征对NP大小转换机制的分析.
- 审查表明MOF NP在抗瘤药物输送中的表现的研究.
主要成果:
- 可变大小的MOFNP增强了血液循环时间和瘤积累.
- 适应尺寸的NP克服了固定尺寸纳米粒子的局限性.
- 基于MOF的可变大小NP显示了针对向抗瘤药物递送的潜力.
结论:
- 基于MOF的可变大小NP为克服癌症治疗中目前纳米载体限制提供了一个有希望的策略.
- 对这些可适应的NP的潜力和挑战进行进一步的研究是多模式组合治疗的必要条件.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


